Adam Meijer to Influenza, Human
This is a "connection" page, showing publications Adam Meijer has written about Influenza, Human.
Connection Strength
0.825
-
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017. Antiviral Res. 2018 09; 157:38-46.
Score: 0.128
-
Case of seasonal reassortant A(H1N2) influenza virus infection, the Netherlands, March 2018. Euro Surveill. 2018 04; 23(15).
Score: 0.125
-
Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes. PLoS One. 2017; 12(1):e0169528.
Score: 0.115
-
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014-2015. Antiviral Res. 2016 08; 132:178-85.
Score: 0.110
-
Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020. Influenza Other Respir Viruses. 2021 07; 15(4):429-438.
Score: 0.038
-
Excess Deaths during Influenza and Coronavirus Disease and Infection-Fatality Rate for Severe Acute Respiratory Syndrome Coronavirus 2, the Netherlands. Emerg Infect Dis. 2021 02; 27(2):411-420.
Score: 0.038
-
The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness. Vaccine. 2018 08 09; 36(33):4993-5001.
Score: 0.032
-
Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically attended influenza: Results of the European I-MOVE multicentre test-negative case-control study, 2011/2012-2016/2017. Influenza Other Respir Viruses. 2018 09; 12(5):567-581.
Score: 0.032
-
2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children. Influenza Other Respir Viruses. 2018 07; 12(4):423-437.
Score: 0.031
-
Pharmacokinetics of favipiravir during continuous venovenous haemofiltration in a critically ill patient with influenza. Antivir Ther. 2018; 23(5):457-461.
Score: 0.031
-
Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections. J Infect Dis. 2017 08 15; 216(4):415-424.
Score: 0.030
-
Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016. Antiviral Res. 2017 Oct; 146:12-20.
Score: 0.030
-
Epidemiological Risk Factors for Animal Influenza A Viruses Overcoming Species Barriers. Ecohealth. 2017 06; 14(2):342-360.
Score: 0.029
-
Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups. Vaccine. 2017 05 15; 35(21):2831-2839.
Score: 0.029
-
Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections. Influenza Other Respir Viruses. 2016 Jan; 10(1):14-26.
Score: 0.027